Skip to content ↓

Arts News

Modern Orchestra premieres work by MIT lecturer

Music and theater arts lecturer Elena Ruehr's "Ladder to the Moon," premiered by The Boston Modern Orchestra Project on March 7, won a glowing review from the Boston Herald. "Inspired by a Georgia O'Keeffe painting, Ruehr beautifully captured the combination of spaciousness and unseen dread that fills much of that artist's work," wrote T. J. Medrek. "Underneath the music's surface serenity, in which short phrases were passed around the orchestra in a jazz-like manner, was a primal energy that built to a powerful climax both thrilling and disturbing--rather like life itself."

Deveau concert well received

Senior lecturer David Deveau's performance of works by Professor Peter Child at the Steinway artists gala at Symphony Hall March 15 was singled out in a Boston Globe review of the event. "David Deveau deserved applause for presenting three of Child's ingenious pieces from 'Doubles,' and for playing them so deliciously."

Role reversal

A March 12 Tech Talk article about Shakespeare Ensemble's production of "Antony and Cleopatra" incorrectly stated that Matthew Lehar was playing messengers and a soothsayer in addition to Octavius Caesar. In fact, senior Jennifer Martinez is playing the roles of messengers to Antony, Caesar and Cleopatra; a Soothsayer; Varrius; Soldier of Antony; and Dolabella. Lehar is portraying Octavius Caesar.

A version of this article appeared in MIT Tech Talk on March 19, 2003.

Related Topics

More MIT News

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story